Search Within

Department of Medicine

Formats
  1. Journal Article (19593)
  2. Meeting Abstract (16038)
  3. Review (1150)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22321)
  2. Hematologic Malignancies, Division of (13278)
  3. Center for Hematologic Malignancies (11061)
  4. GSK Faculty (10646)
  5. Survivorship Research (9330)
  6. Division of Subspecialty Medicine (7535)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1071)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2111)

More Publishers

Results (39622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ectopic Cushing syndrome: A diagnostic anomaly of malignancy
    Meeting Abstract

    Oguntuwase, E. F.; Flombaum, C. D.; Glezerman, I.; Gutgarts, V.
    Journal of the American Society of Nephrology (2024)

    Fulltext@MSK | Save
  • Drug-induced thrombotic microangiopathy from cancer therapies: A clinicopathologic series
    Meeting Abstract

    Pak, W. L. W.; Knezevic, A.; Salvatore, S.; Seshan, S. V.; Glezerman, I.; Jaimes, E. A.; Jaffer Sathick, I.
    Journal of the American Society of Nephrology (2024)

    Fulltext@MSK | Save
  • Gamma-secretase inhibitor-associated hypophosphatemia in patients with desmoid tumors
    Meeting Abstract

    Pak, W. L. W.; Jaimes, E. A.; Knezevic, A.; Agins, J.; Jhaveri, K. D.; Shaikh, A.
    Journal of the American Society of Nephrology (2024)

    Fulltext@MSK | Save
  • Kidney-targeting mesoscale nanoparticles for delivery of gene therapy in CKD
    Meeting Abstract

    Jaimes, E. A.; Vasylaki, A.; Roach, A.; Ghosh, P.; Baltaci, M.; Williams, R.
    Journal of the American Society of Nephrology (2024)

    Fulltext@MSK | Save
  • An unusual case of steroid refractory allergic interstitial nephritis related to prior ifosfamide exposure
    Meeting Abstract

    Sardar, S.; Matarneh, A.; Gutgarts, V.; Trivedi, N.; Ghahramani, N.
    Journal of the American Society of Nephrology (2024)

    Fulltext@MSK | Save
  • Percutaneous kidney biopsy in patients with metastatic solid malignancy and AKI on systemic anticancer therapy
    Meeting Abstract

    Milanez, T.; Srinivasan, V.; Ocvirk, J.; Jaimes, E. A.
    Journal of the American Society of Nephrology (2024)

    Fulltext@MSK | Save
  • IgG4-tubulointerstitial nephritis due to pembrolizumab
    Meeting Abstract

    Won, A. H.; Salvatore, S.; Sathick, I. J.
    Journal of the American Society of Nephrology (2024)

    Fulltext@MSK | Save
  • A phase 2, open-label, single-arm, prospective, multicenter study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer
    Meeting Abstract

    Dockery, L.; Musa, F.; Mathews, C.; Spirtos, N.; Slomovitz, B.; Priebe, A.; Green, A.; Puechl, A.; Birrer, M.; Herzog, T.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Dose-expansion part of a phase 1b global study of E7386 plus lenvatinib in patients with hepatocellular carcinoma and other solid tumors including endometrial cancer
    Meeting Abstract

    Lee, J. Y.; Ryoo, B. Y.; Kim, J. W.; Cheng, A. L.; Finn, R. S.; Hasegawa, K.; Makker, V.; Kudo, M.; Miller, D. S.; Merle, P.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Upgrade: Phase 1 trial of the NaPi2b-directed dolaflexin antibody drug conjugate UpRi in combination with carboplatin in patients with platinum-sensitive ovarian cancer (PSOC)
    Meeting Abstract

    Friedman, C.; Anderson, C.; Hays, J.; Lakhani, N.; Buscema, J.; Hamilton, E.; Taylor, S.; Duska, L.; Cloven, N.; Reske, A.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save